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The actin panel in the original version of [Fig. 5 B](#fig5){ref-type="fig"} was flipped horizontally, and the [Fig. 5 B](#fig5){ref-type="fig"} and [Fig. 6 C](#fig6){ref-type="fig"} legends did not indicate the intentional duplication of the 3 and 4 d actin data. In addition, the HIF-2α panel in the original version of [Fig. 7 C](#fig7){ref-type="fig"} was a duplicate of the HIF-2α panel in [Fig. 6 F](#fig6){ref-type="fig"}. The authors have indicated that these issues were due to clerical errors during figure and manuscript preparation. Corrected versions of [Fig. 5 B](#fig5){ref-type="fig"} and [Fig. 7 C](#fig7){ref-type="fig"} and of the [Fig. 5 B](#fig5){ref-type="fig"} and [Fig. 6 C](#fig6){ref-type="fig"} legends are shown below.

![(B) EBs were cultured for 1--4 d and analyzed by immunoblotting for cleaved caspase-3 (cas-3) and actin. Ablation of AIF inhibited caspase-3 activation. The 3 and 4 d actin data are the same as those in [Fig. 6 C](#fig6){ref-type="fig"}, where the same blots were analyzed for Bnip3 levels.](JCB_201111063_Fig5){#fig5}

###### 

\(C\) AIF^y/+^ and AIF^y/−^ EBs were cultured for 3--5 d and analyzed for Bnip3 by immunoblotting. Bnip3 expression was significantly reduced in the absence of AIF. The 3 and 4 d actin data are the same as those in [Fig. 5 B](#fig5){ref-type="fig"}, where the same blots were analyzed for cleaved cas-3 levels.

![(C) 2-d AIF^y/+^ EBs were treated with or without 2 µM EUK134 for 24 h. Immunoblots show that EUK134 treatment reduced the expression of HIF-1α, HIF-2α, Bnip3, and cleaved caspase-3.](JCB_201111063_Fig7){#fig7}

The html and pdf versions of this article have been corrected. The errors remain only in the print version.
